Related Experiment Video
Updated: May 26, 2026

Deep Neuromuscular Blockade Leads to a Larger Intraabdominal Volume During Laparoscopy
Published on: June 25, 2013
Successful management of rocuronium-induced anaphylactic reactions with sugammadex: a case report
Takashi Kawano1, Takahiko Tamura, Mayuko Hamaguchi
1Department of Anesthesiology and Critical Care Medicine, Kochi Medical School, Kochi, 783-8505, Japan. takashika@kochi-u.ac.jp
Abstract:
Sugammadex, a new reversal agent for rocuronium, encapsulates the rocuronium molecule and results in rapid reversal of rocuronium-induced neuromuscular blockade. A case in which sugammadex was used to treat an anaphylactic reaction that occurred after rocuronium is presented. The binding/encapsulation of rocuronium by sugammadex may selectively eliminate the antigenic quaternary ammonium activity of circulating rocuronium, and prevent the propagation of rocuronium-induced anaphylaxis.
Related Concept Videos
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Depolarizing Blockers: Pharmocokinetics
Skeletal Muscle Relaxants: Therapeutic Uses
Allergic Reactions: Anaphylaxis
Allergic Reactions
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...